Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul;14(4):432-436.
doi: 10.1007/s12072-020-10043-z. Epub 2020 Apr 10.

Management of COVID-19 in patients after liver transplantation: Beijing working party for liver transplantation

Hongling Liu  1 , Xi He  1 , Yudong Wang  2 , Shuangnan Zhou  1 , Dali Zhang  1 , Jiye Zhu  3 , Qiang He  4 , Zhijun Zhu  5 , Guangming Li  6 , Libo Sun  6 , Jianli Wang  7 , Gregory Cheng  2 , Zhenwen Liu  8 , George Lau  9   10
Affiliations

Management of COVID-19 in patients after liver transplantation: Beijing working party for liver transplantation

Hongling Liu et al. Hepatol Int. 2020 Jul.

Abstract

Annually, around 850 liver transplantation is performed in Beijing, China. Recently, the new coronavirus pneumonia (COVID-19) caused by 2019 novel coronavirus (2019-nCoV) has affected nearly 200 countries worldwide. 2019-nCov can cause severe lung disease, multiple-organ damage, and significant mortalities. Liver transplant recipients, because of long-term oral immunosuppressant effects, may be more susceptible to 2019-nCoV infection and have a worse prognosis than the general population. It is urgent to set up guidelines for the prevention, diagnosis, and treatment of COVID-19 in liver transplant recipients. In this article, we reviewed the clinical aspects of 2019-nCoV infection, characteristics of liver transplant recipients, immunosuppressant usage, and potential drug interactions to provide recommendations to clinical staff managing liver transplant recipients during the COVID-19 epidemic.

Keywords: 2019-nCoV; COVID-19; Liver transplantation; Management.

PubMed Disclaimer

Conflict of interest statement

Hongling Liu, Xi He, Yudong Wang, Shuangnan Zhou, Dali Zhang, Jiye Zhu, Qiang He, Zhijun Zhu, Guangming Li, Libo Sun, Jianli Wang, Gregory Cheng, Zhenwen Liu, George Lau declare that they do not have any conflict of interest.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. China National Health Commission. National Health and Health Commission's plan for the diagnosis and treatment of new coronavirus pneumonia (trial version 7)
    1. Chen S, Zhang WJ, Chen G, et al. Guidance on clinical diagnosis, treatment and transplantation of 2019-nCoV infected organ transplant recipients (First Edition). 10.3760/cma.j.issn.0254. http://rs.yigle.com/m/yufabiao/1181145.htm
    1. Liu Z, Xiao X, Wei X, et al. Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2. J Med Virol. 2020 doi: 10.1002/jmv.25726. - DOI - PMC - PubMed
    1. Expert group on prevention and control of new coronavirus pneumonia of Chinese Preventive Medicine Association New understanding of epidemiological characteristics of COVID-19. Chin J Epidemiol. 2020;41(2):139–144. - PubMed
    1. Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of 2019 novel coronavirus infection in China. New Engl J Med. 2020 doi: 10.1056/NEJMoa2002032. - DOI - PubMed

MeSH terms